Tal Zaks's most recent trade in Teva- Pharmaceutical Industries Ltd. - ADR was a trade of 14,492 Restricted Share Units done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Teva- Pharmaceutical Indus... | Tal Zaks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 14,492 | 14,492 | - | - | Restricted Share Units | |
| Teva- Pharmaceutical Indus... | Tal Zaks | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2025 | 9,632 | 58,772 (0%) | 0% | - | Ordinary Shares | |
| Teva- Pharmaceutical Indus... | Tal Zaks | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2025 | 9,632 | 0 | - | - | Restricted Share Units | |
| Teva- Pharmaceutical Indus... | Tal Zaks | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 21,108 | 49,140 (0%) | 0% | - | Ordinary Shares | |
| Teva- Pharmaceutical Indus... | Tal Zaks | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 21,108 | 0 | - | - | Restricted Share Units | |
| Teva- Pharmaceutical Indus... | Tal Zaks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 9,632 | 9,632 | - | - | Restricted Share Units | |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.93 per share. | 30 Jun 2021 | 5,000 | 5,000 (0%) | 0% | 25.9 | 129,650 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 237.00 per share. | 30 Jun 2021 | 5,000 | 0 (0%) | 0% | 237 | 1,185,000 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2021 | 5,000 | 121,120 | - | - | Stock Option (Right to Buy) | |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.93 per share. | 23 Jun 2021 | 5,000 | 5,000 (0%) | 0% | 25.9 | 129,650 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2021 | 5,000 | 126,120 | - | - | Stock Option (Right to Buy) | |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 219.65 per share. | 23 Jun 2021 | 5,000 | 0 (0%) | 0% | 219.7 | 1,098,250 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2021 | 5,000 | 131,120 | - | - | Stock Option (Right to Buy) | |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 200.00 per share. | 16 Jun 2021 | 5,000 | 0 (0%) | 0% | 200 | 1,000,000 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.93 per share. | 16 Jun 2021 | 5,000 | 5,000 (0%) | 0% | 25.9 | 129,650 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2021 | 5,000 | 136,120 | - | - | Stock Option (Right to Buy) | |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 212.30 per share. | 09 Jun 2021 | 5,000 | 0 (0%) | 0% | 212.3 | 1,061,500 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.93 per share. | 09 Jun 2021 | 5,000 | 5,000 (0%) | 0% | 25.9 | 129,650 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.93 per share. | 02 Jun 2021 | 5,000 | 5,000 (0%) | 0% | 25.9 | 129,650 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 183.90 per share. | 02 Jun 2021 | 5,000 | 0 (0%) | 0% | 183.9 | 919,500 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2021 | 5,000 | 141,120 | - | - | Stock Option (Right to Buy) | |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2021 | 5,000 | 146,120 | - | - | Stock Option (Right to Buy) | |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 168.70 per share. | 26 May 2021 | 5,000 | 0 (0%) | 0% | 168.7 | 843,500 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.93 per share. | 26 May 2021 | 5,000 | 5,000 (0%) | 0% | 25.9 | 129,650 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 155.74 per share. | 19 May 2021 | 5,000 | 0 (0%) | 0% | 155.7 | 778,700 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2021 | 5,000 | 151,120 | - | - | Stock Option (Right to Buy) | |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.93 per share. | 19 May 2021 | 5,000 | 5,000 (0%) | 0% | 25.9 | 129,650 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 154.11 per share. | 12 May 2021 | 5,000 | 0 (0%) | 0% | 154.1 | 770,550 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.93 per share. | 12 May 2021 | 5,000 | 5,000 (0%) | 0% | 25.9 | 129,650 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2021 | 5,000 | 156,120 | - | - | Stock Option (Right to Buy) | |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2021 | 3,670 | 137,612 | - | - | Stock Option (Right to Buy) | |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.21 per share. | 10 May 2021 | 3,670 | 3,670 (0%) | 0% | 12.2 | 44,811 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 158.88 per share. | 10 May 2021 | 1,585 | 500 (0%) | 0% | 158.9 | 251,825 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 157.48 per share. | 10 May 2021 | 985 | 2,085 (0%) | 0% | 157.5 | 155,118 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 156.60 per share. | 10 May 2021 | 600 | 3,070 (0%) | 0% | 156.6 | 93,960 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 163.12 per share. | 10 May 2021 | 200 | 0 (0%) | 0% | 163.1 | 32,624 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 159.63 per share. | 10 May 2021 | 200 | 300 (0%) | 0% | 159.6 | 31,926 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 161.64 per share. | 10 May 2021 | 100 | 200 (0%) | 0% | 161.6 | 16,164 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.21 per share. | 03 May 2021 | 5,000 | 5,000 (0%) | 0% | 12.2 | 61,050 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2021 | 5,000 | 141,282 | - | - | Stock Option (Right to Buy) | |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 187.10 per share. | 03 May 2021 | 1,924 | 916 (0%) | 0% | 187.1 | 359,980 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 186.04 per share. | 03 May 2021 | 1,089 | 2,840 (0%) | 0% | 186.0 | 202,598 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 188.00 per share. | 03 May 2021 | 916 | 0 (0%) | 0% | 188 | 172,208 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 184.77 per share. | 03 May 2021 | 800 | 3,929 (0%) | 0% | 184.8 | 147,816 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 183.42 per share. | 03 May 2021 | 271 | 4,729 (0%) | 0% | 183.4 | 49,707 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.21 per share. | 26 Apr 2021 | 5,000 | 5,000 (0%) | 0% | 12.2 | 61,050 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2021 | 5,000 | 146,282 | - | - | Stock Option (Right to Buy) | |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 178.51 per share. | 26 Apr 2021 | 1,829 | 100 (0%) | 0% | 178.5 | 326,495 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 177.41 per share. | 26 Apr 2021 | 900 | 1,929 (0%) | 0% | 177.4 | 159,669 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 169.87 per share. | 26 Apr 2021 | 580 | 4,420 (0%) | 0% | 169.9 | 98,525 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 175.97 per share. | 26 Apr 2021 | 551 | 2,829 (0%) | 0% | 176.0 | 96,959 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 171.05 per share. | 26 Apr 2021 | 439 | 3,981 (0%) | 0% | 171.1 | 75,091 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 175.03 per share. | 26 Apr 2021 | 400 | 3,380 (0%) | 0% | 175.0 | 70,012 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 173.03 per share. | 26 Apr 2021 | 200 | 3,780 (0%) | 0% | 173.0 | 34,606 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 179.37 per share. | 26 Apr 2021 | 100 | 0 (0%) | 0% | 179.4 | 17,937 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 172.00 per share. | 26 Apr 2021 | 1 | 3,980 (0%) | 0% | 172 | 172 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.21 per share. | 19 Apr 2021 | 5,000 | 5,000 (0%) | 0% | 12.2 | 61,050 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2021 | 5,000 | 151,282 | - | - | Stock Option (Right to Buy) | |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 161.62 per share. | 19 Apr 2021 | 1,332 | 3,012 (0%) | 0% | 161.6 | 215,278 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 162.65 per share. | 19 Apr 2021 | 1,250 | 1,762 (0%) | 0% | 162.7 | 203,313 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 166.31 per share. | 19 Apr 2021 | 700 | 100 (0%) | 0% | 166.3 | 116,417 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 160.48 per share. | 19 Apr 2021 | 656 | 4,344 (0%) | 0% | 160.5 | 105,275 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 163.89 per share. | 19 Apr 2021 | 500 | 1,262 (0%) | 0% | 163.9 | 81,945 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 165.04 per share. | 19 Apr 2021 | 462 | 800 (0%) | 0% | 165.0 | 76,248 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 167.56 per share. | 19 Apr 2021 | 100 | 0 (0%) | 0% | 167.6 | 16,756 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2021 | 5,000 | 156,282 | - | - | Stock Option (Right to Buy) | |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.21 per share. | 12 Apr 2021 | 5,000 | 5,000 (0%) | 0% | 12.2 | 61,050 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 139.38 per share. | 12 Apr 2021 | 1,824 | 913 (0%) | 0% | 139.4 | 254,229 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 138.06 per share. | 12 Apr 2021 | 1,400 | 2,737 (0%) | 0% | 138.1 | 193,284 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 137.16 per share. | 12 Apr 2021 | 863 | 4,137 (0%) | 0% | 137.2 | 118,369 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 140.22 per share. | 12 Apr 2021 | 413 | 500 (0%) | 0% | 140.2 | 57,911 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 141.79 per share. | 12 Apr 2021 | 400 | 100 (0%) | 0% | 141.8 | 56,716 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 143.09 per share. | 12 Apr 2021 | 100 | 0 (0%) | 0% | 143.1 | 14,309 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.21 per share. | 05 Apr 2021 | 5,000 | 5,000 (0%) | 0% | 12.2 | 61,050 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2021 | 5,000 | 161,282 | - | - | Stock Option (Right to Buy) | |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 129.96 per share. | 05 Apr 2021 | 2,426 | 2,574 (0%) | 0% | 130.0 | 315,283 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 130.95 per share. | 05 Apr 2021 | 1,150 | 0 (0%) | 0% | 131.0 | 150,593 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 128.65 per share. | 05 Apr 2021 | 814 | 1,150 (0%) | 0% | 128.6 | 104,721 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 127.76 per share. | 05 Apr 2021 | 610 | 1,964 (0%) | 0% | 127.8 | 77,934 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.93 per share. | 22 Mar 2021 | 1,199 | 1,199 (0%) | 0% | 20.9 | 25,095 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Mar 2021 | 1,199 | 169,599 | - | - | Stock Option (Right to Buy) | |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 144.06 per share. | 22 Mar 2021 | 366 | 578 (0%) | 0% | 144.1 | 52,726 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 146.46 per share. | 22 Mar 2021 | 290 | 61 (0%) | 0% | 146.5 | 42,473 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 142.83 per share. | 22 Mar 2021 | 255 | 944 (0%) | 0% | 142.8 | 36,422 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 145.47 per share. | 22 Mar 2021 | 227 | 351 (0%) | 0% | 145.5 | 33,022 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 147.51 per share. | 22 Mar 2021 | 61 | 0 (0%) | 0% | 147.5 | 8,998 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 10,000 | 170,798 | - | - | Stock Option (Right to Buy) | |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.93 per share. | 15 Mar 2021 | 10,000 | 10,000 (0%) | 0% | 20.9 | 209,300 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 141.31 per share. | 15 Mar 2021 | 2,988 | 3,058 (0%) | 0% | 141.3 | 422,234 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 142.17 per share. | 15 Mar 2021 | 2,101 | 957 (0%) | 0% | 142.2 | 298,699 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 140.38 per share. | 15 Mar 2021 | 1,874 | 6,046 (0%) | 0% | 140.4 | 263,072 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 143.09 per share. | 15 Mar 2021 | 957 | 0 (0%) | 0% | 143.1 | 136,937 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 137.00 per share. | 15 Mar 2021 | 801 | 8,822 (0%) | 0% | 137 | 109,737 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 138.26 per share. | 15 Mar 2021 | 602 | 8,220 (0%) | 0% | 138.3 | 83,233 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 136.00 per share. | 15 Mar 2021 | 411 | 9,623 (0%) | 0% | 136 | 55,896 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 139.09 per share. | 15 Mar 2021 | 300 | 7,920 (0%) | 0% | 139.1 | 41,727 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 34 | 40,141 | - | - | Stock Option (Right to Buy) | |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.21 per share. | 15 Mar 2021 | 34 | 10,034 (0%) | 0% | 14.2 | 483 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2021 | 10,000 | 180,798 | - | - | Stock Option (Right to Buy) | |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.93 per share. | 08 Mar 2021 | 10,000 | 10,000 (0%) | 0% | 20.9 | 209,300 | Common Stock |
| Moderna | Tal Zaks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2021 | 5,000 | 40,175 | - | - | Stock Option (Right to Buy) |